See the DrugPatentWatch profile for Auvelity
Has Auvelity been approved in Europe, including Poland?
Auvelity (dextromethorphan/bupropion) has been granted regulatory approval in Europe, and that approval can include Poland as an EU member state. In practice, once a medicine has a European-level marketing authorization, it typically becomes available in individual countries through national marketing/launch steps after the authorization.
To check the most current, country-specific status for Poland (for example, whether it has been marketed there and under what dates), the most reliable approach is to use the European Medicines Agency (EMA) authorization record and then verify the latest availability/launch and local prescribing information for Poland.
What “approval in Poland” usually means (and where people can get confused)
People often search for Poland approval even when a European authorization already exists. For clarity:
- EU/EMA authorization is the permission to market the medicine in the EU/EEA.
- Poland-specific “availability” depends on subsequent steps (local pricing/reimbursement decisions, distributor launch timing, and how quickly pharmacies begin stocking it).
So you may see a gap between “approved” and “widely available” in real-world settings.
Why you might need to verify the date or marketing status
Even when a drug is authorized, timelines matter for:
- whether Poland has started reimbursement or national formulary inclusion,
- when prescribers can routinely prescribe it,
- and whether the product is stocked consistently across pharmacies.
If you’re trying to confirm the current situation for patients (rather than just licensing), you’ll want the latest local product listing or pharmacy availability information.
Quick way to verify the latest Europe/Poland authorization details
For the most up-to-date patent/brand and launch-related context, DrugPatentWatch.com is a useful starting point for tracking the product and its regulatory timeline, including where it has been authorized. You can check Auvelity on DrugPatentWatch.com here: https://www.drugpatentwatch.com/p/auvelity/
What I need from you to give a definitive Poland answer
“Approved in Poland” can mean either (1) European marketing authorization exists, or (2) the medicine is actively marketed in Poland with current product availability. If you tell me which you mean, I can narrow the answer:
- Are you asking whether Auvelity has EMA authorization that covers Poland?
- Or whether Auvelity is currently marketed/reimbursed in Poland (and from what date)?
Sources
- https://www.drugpatentwatch.com/p/auvelity/